59
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy

, , , , , , & show all
Pages 1065-1075 | Published online: 24 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Peter P Toth, Kamlesh M Thakker, Ping Jiang & Robert J Padley. (2012) Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy. Vascular Health and Risk Management 8, pages 39-44.
Read now
Rahul Yadav, Michael France, Naveed Younis, Salam Hama, Basil J Ammori, See Kwok & Handrean Soran. (2012) Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety. Expert Opinion on Pharmacotherapy 13:9, pages 1345-1362.
Read now

Articles from other publishers (4)

Sebnem Garip, Sevgi Haman Bayari, Mete Severcan, Sherif Abbas, Igor K. Lednev & Feride Severcan. (2016) Structural effects of simvastatin on rat liver tissue: Fourier transform infrared and Raman microspectroscopic studies. Journal of Biomedical Optics 21:2, pages 025008.
Crossref
Ulrich Julius. (2015) Niacin as antidyslipidemic drug. Canadian Journal of Physiology and Pharmacology 93:12, pages 1043-1054.
Crossref
Stephen P Adams, Michael Tsang & James M Wright. (2015) Atorvastatin for lowering lipids. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Stephen P Adams, Michael Tsang & James M Wright. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.